Company Filing History:
Years Active: 2017
Title: Georg Strieder: Innovator in Pharmaceutical Composition
Introduction
Georg Strieder is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of essential thrombocythemia. His innovative approach has led to the development of a unique composition that addresses this medical condition effectively.
Latest Patents
Georg Strieder holds 1 patent for his invention titled "Composition for treatment of essential thrombocythemia." This patent describes a novel pharmaceutical composition that is free of gastric coating. It comprises anagrelide hydrochloride combined with a non-pH dependent polymer and a pharmaceutically acceptable water-soluble acid. This composition is designed for the treatment of essential thrombocythemia, showcasing Strieder's commitment to advancing medical treatments.
Career Highlights
Throughout his career, Georg Strieder has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with AOP Orphan Pharmaceuticals AG and AOP Orphan Pharmaceuticals AC. His work in these organizations has allowed him to collaborate with other experts and contribute to significant advancements in pharmaceutical research.
Collaborations
One of his notable coworkers is Rudolf Stefan Widmann. Their collaboration has likely fostered innovative ideas and solutions in their respective fields.
Conclusion
Georg Strieder's contributions to pharmaceutical innovation, particularly in the treatment of essential thrombocythemia, highlight his role as a significant inventor. His patent and collaborations reflect his dedication to improving medical treatments and advancing the pharmaceutical industry.